COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL studyThomas Chatzikonstantinou, Elżbieta Kalicińska, Anargyros Kapetanakis et al.|Leukemia|2021Cited by 94
Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trialRudolf Benz, Georg Stüssi, Martin Andres et al.|Blood Advances|2020Cited by 31
The evolving landscape of <scp>COVID</scp>‐19 and <scp>post‐COVID</scp> condition in patients with chronic lymphocytic leukemia: A study by <scp>ERIC</scp>, the <scp>European</scp> research initiative on <scp>CLL</scp>Andrea Visentin, Gilad Itchaki, Thomas Chatzikonstantinou et al.|American Journal of Hematology|2023Cited by 21
Acquired hemophilia A and plasma cell neoplasms: a case report and review of the literatureKatarzyna Aleksandra Jalowiec, Johanna A. Kremer Hovinga, Martin Andres et al.|Journal of Medical Case Reports|2020Cited by 14
Obinutuzumab in two patients suffering from immune‐mediated thrombotic thrombocytopenic purpura intolerant to rituximabJudith Robertz, Johanna A. Kremer Hovinga, Martin Andres et al.|American Journal of Hematology|2019Cited by 13